Duligotuzumab

Monoclonal antibody

Duligotuzumab (INN) is a bispecific humanized IgG1 monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFR and HER3. It is in development by Roche.

Read it on Wikipedia · Version rolled

BasicBottom 25%

23,590SP

Badges16 earned

.intNotable+9,063 SP
Links to an international organization (.int).
ZebraNotable+6,936 SP
The title's letters alternate vowel and consonant (7+ letters).
HubNotable+3,119 SP
500+ articles link here. · 517 articles link here
- Noticed Hereearned
- Known Aroundearned
- Well Knownearned

Basic13

DuligotuzumabDuligotuzumab

Badges16 earned

Duligotuzumab